Generic Drug Interchangeability
Generic Drug Interchangeability is a pharmacoeconomic and regulatory construct that denotes the scientific and clinical determination that a generic drug product can be substituted for a brand-name drug product without significant difference in safety, efficacy, or intended effect under the conditions of intended use, thereby enabling therapeutic equivalence within health system frameworks.
43
Publications
1.1K
Citations
131
Authors
68
Institutions
Publications per year
2017–2026
8
Parents
43
Generic Products of Antiepileptic Drugs (AEDs): Is It an Issue?
Meir Bialer · Epilepsia · 2007 · 80 citations · Full text
1–5 of 43
131
3
h-index
3
h-index
2
h-index
2
h-index
2
h-index
1–5 of 131
68

University of Toronto
Toronto, Canada
3 h-index
3 publications
92 citations
Medicines Evaluation Board
Utrecht, Netherlands
3 h-index
9 publications
200 citations
St. Joseph’s Healthcare Hamilton
Hamilton, Canada
3 h-index
5 publications
149 citations

King Saud University
Riyadh, Saudi Arabia
2 h-index
2 publications
45 citations
Semmelweis University
Budapest, Hungary
2 h-index
2 publications
55 citations

University of Wisconsin System
Madison, United States
2 h-index
3 publications
81 citations

University of Cincinnati
Cincinnati, United States
2 h-index
2 publications
67 citations

McMaster University
Hamilton, Canada
2 h-index
6 publications
195 citations
1–8 of 68
Repository · 7 publications · 224 citations
7
h-index
CPT · 4 publications · 94 citations
4
h-index
2 publications · 48 citations
2
h-index
2 publications · 36 citations
2
h-index
JBS · 2 publications · 47 citations
2
h-index
1–5